Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Genetic causes of heart failure with preserved ejection fraction: emerging pharmacological treatments
Iacopo Olivotto, James E. Udelson, Maurizio Pieroni, et al.
European Heart Journal (2022) Vol. 44, Iss. 8, pp. 656-667
Open Access | Times Cited: 23

Showing 23 citing articles:

From gene-discovery to gene-tailored clinical management: 25 years of research in channelopathies and cardiomyopathies
Lia Crotti, Pedro Brugada, Hugh Calkins, et al.
EP Europace (2023) Vol. 25, Iss. 8
Open Access | Times Cited: 23
Anderson–Fabry disease management: role of the cardiologist
Maurizio Pieroni, Mehdi Namdar, Iacopo Olivotto, et al.
European Heart Journal (2024) Vol. 45, Iss. 16, pp. 1395-1409
Open Access | Times Cited: 14
The sympathetic nervous system in heart failure revisited
Filippos Triposkiadis, Αlexandros Briasoulis, Takeshi Kitai, et al.
Heart Failure Reviews (2023) Vol. 29, Iss. 2, pp. 355-365
Closed Access | Times Cited: 17
Left atrial structural and functional remodelling in Fabry disease and cardiac amyloidosis: A comparative analysis
Maria Chiara Meucci, Rosa E. Lillo, Federica Mango, et al.
International Journal of Cardiology (2024) Vol. 402, pp. 131891-131891
Closed Access | Times Cited: 7
Impact of Case and Control Selection on Training Artificial Intelligence Screening of Cardiac Amyloidosis
Amey Vrudhula, L. Stern, Paul Cheng, et al.
JACC Advances (2024) Vol. 3, Iss. 9, pp. 100998-100998
Open Access | Times Cited: 6
H2FPEF and HFA‐PEFF scores for heart failure risk stratification in hypertrophic cardiomyopathy patients
Ying Gao, Hongyun Liu, Xiaojun Bi, et al.
ESC Heart Failure (2025)
Open Access
Phenotype-Based Classification of Obstructive Hypertrophic Cardiomyopathy Undergoing Myomectomy
Hao Cui, Hao Nie, Congrui Wang, et al.
JACC Basic to Translational Science (2025)
Open Access
The Goldilocks for chronic weight management—Balancing quantity with quality of weight loss
Kim Henriksen, Manu V. Chakravarthy, Cecilie Liv Bager, et al.
Diabetes Obesity and Metabolism (2025)
Closed Access
2024 Guidelines of the Taiwan Society of Cardiology for the Diagnosis and Treatment of Heart Failure with Preserved Ejection Fraction.
Yi‐Heng Li, Chun‐Chieh Wang, Chung‐Lieh Hung, et al.
PubMed (2024) Vol. 40, Iss. 2, pp. 148-171
Closed Access | Times Cited: 2
Safety, tolerability, pharmacokinetics, and pharmacodynamics of a soluble guanylate cyclase stimulator, HEC95468, in healthy volunteers: a randomized, double-blinded, placebo-controlled phase 1 trial
Yuzhou Gui, Wei Wang, Qingqing Wu, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 2
Schaftoside improves HFpEF through regulation the autophagy-lysosome pathway by allosterically targeting CaMKII-δ
Haiying Zhang, Yanan Gao, Min Zhang, et al.
Redox Biology (2024) Vol. 78, pp. 103424-103424
Open Access | Times Cited: 2
Identification of a novel splicing‐altering LAMP2 variant in a Chinese family with Danon disease
Di Fu, Shuai Wang, Yonghong Luo, et al.
ESC Heart Failure (2023) Vol. 10, Iss. 4, pp. 2479-2486
Open Access | Times Cited: 4
The Promising Role of Selenium and Yeast in the Fight Against Protein Amyloidosis
Marek Kieliszek, Katsiaryna Sapazhenkava
Biological Trace Element Research (2024)
Open Access | Times Cited: 1
Heart failure with preserved ejection fraction: the need for a better genetic characterization
Emanuele Monda, Giuseppe Limongelli
European Heart Journal - Cardiovascular Imaging (2023) Vol. 24, Iss. 5, pp. e89-e89
Closed Access | Times Cited: 3
Comprehensive diagnostic workup in patients with suspected heart failure and preserved ejection fraction
Stefano Albani, Filippo Zilio, Pietro Scicchitano, et al.
Hellenic Journal of Cardiology (2023) Vol. 75, pp. 60-73
Open Access | Times Cited: 3
Development and Challenges of Pre-Heart Failure with Preserved Ejection Fraction
Guoju Dong
Reviews in Cardiovascular Medicine (2023) Vol. 24, Iss. 9
Open Access | Times Cited: 3
Heart failure: from pathophysiology to deep learning-based outcome prediction
Filippo Crea
European Heart Journal (2023) Vol. 44, Iss. 8, pp. 629-632
Open Access | Times Cited: 2
Schaftoside Improves Hfpef Through Regulation the Autophagy-Lysosome Pathway by Allosterically Targeting Camkii-Δ
haiying Zhang, Yanan Gao, Min Zhang, et al.
(2024)
Closed Access
A focus on two rapidly expanding fields: cardio-oncology and genetics
Filippo Crea
European Heart Journal (2024) Vol. 45, Iss. 34, pp. 3095-3099
Closed Access
Schaftoside Improves Hfpef Through Regulation the Autophagy-Lysosome Pathway by Allosterically Targeting Camkii-Δ
Yan Liu, haiying Zhang, Yanan Gao, et al.
(2024)
Closed Access
Impact of Case and Control Selection on Training AI Screening of Cardiac Amyloidosis
Amey Vrudhula, L. Stern, Paul Cheng, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Cardiomyopathies: Yesterday, Today, and Tomorrow
Charles Mady, Diane Xavier de Ávila, Vagner Madrini, et al.
ABC Heart Failure & Cardiomyopathy (2023) Vol. 3, Iss. 1
Open Access
Insuficiencia cardiaca con fracción de eyección preservada: ¿identificamos fenotipos o individualizamos la valoración?
Francesç Formiga, Julio Núñez
Revista Española de Geriatría y Gerontología (2023) Vol. 59, Iss. 3, pp. 101425-101425
Closed Access
Page 1

Scroll to top